Skip to main content
B

BEIJING HOTGEN BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 688068 Shanghai Stock Exchange Manufacturing
Filings indexed 868 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688068

About BEIJING HOTGEN BIOTECH CO., LTD.

Beijing Hotgen Biotech Co., Ltd. specializes in the research, development, and manufacturing of in vitro diagnostic (IVD) products. The company utilizes advanced technology platforms, including Up-converting Phosphor Technology (UPT), chemiluminescence immunoassay (CLIA), and molecular diagnostics. Its product portfolio encompasses a wide range of rapid diagnostic kits and automated analyzers designed for the detection of infectious diseases, cardiovascular conditions, hepatic fibrosis, and inflammatory markers. Hotgen Biotech is recognized for its contributions to global public health through the provision of high-sensitivity antigen and antibody testing solutions. The company serves clinical laboratories, hospitals, and point-of-care settings, focusing on delivering accurate, efficient, and user-friendly diagnostic tools to improve patient outcomes and disease management.

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.